ACADIA Pharmaceuticals to Present at the 24th Annual Credit Suisse Healthcare Conference on November 10, 2015
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that it will present at the 24th Annual Credit Suisse Healthcare Conference on Tuesday, November 10, 2015, at 11:30 a.m. Mountain Standard Time in Scottsdale, Arizona. A live webcast of ACADIA’s presentation will be accessible on the company’
